Silverfin false false 31/12/2023 01/01/2023 31/12/2023 A Keeling 28/11/2014 D Keeling 28/11/2014 25 September 2024 no description of principal activity 08571410 2023-12-31 08571410 bus:Director1 2023-12-31 08571410 bus:Director2 2023-12-31 08571410 core:CurrentFinancialInstruments 2023-12-31 08571410 core:CurrentFinancialInstruments 2022-12-31 08571410 2022-12-31 08571410 core:ShareCapital 2023-12-31 08571410 core:ShareCapital 2022-12-31 08571410 core:RetainedEarningsAccumulatedLosses 2023-12-31 08571410 core:RetainedEarningsAccumulatedLosses 2022-12-31 08571410 2023-01-01 2023-12-31 08571410 bus:FilletedAccounts 2023-01-01 2023-12-31 08571410 bus:SmallEntities 2023-01-01 2023-12-31 08571410 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 08571410 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 08571410 bus:Director1 2023-01-01 2023-12-31 08571410 bus:Director2 2023-01-01 2023-12-31 08571410 2022-01-01 2022-12-31 08571410 1 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure

Company No: 08571410 (England and Wales)

INJURY ASSESS LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2023
Pages for filing with the registrar

INJURY ASSESS LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2023

Contents

INJURY ASSESS LIMITED

BALANCE SHEET

As at 31 December 2023
INJURY ASSESS LIMITED

BALANCE SHEET (continued)

As at 31 December 2023
2023 2022
£ £
Current assets
Debtors 3 17,202 27,107
Cash at bank and in hand 2,255 1,088
19,457 28,195
Creditors: amounts falling due within one year 4 ( 53,618) ( 59,648)
Net current liabilities (34,161) (31,453)
Total assets less current liabilities (34,161) (31,453)
Net liabilities ( 34,161) ( 31,453)
Capital and reserves
Called-up share capital 2 2
Profit and loss account ( 34,163 ) ( 31,455 )
Total shareholder's deficit ( 34,161) ( 31,453)

For the financial year ending 31 December 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Injury Assess Limited (registered number: 08571410) were approved and authorised for issue by the Board of Directors on 25 September 2024. They were signed on its behalf by:

A Keeling
Director
INJURY ASSESS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2023
INJURY ASSESS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Injury Assess Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 5 Woodcote View, Wilmslow, SK9 2DT, England, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The company generated a loss for the year of £815 (2022: loss £1,463).

At 31 December 2023, the company had net current liabilities and net liabilities of £32,268 (2022: £31,453).

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. The following criteria must also be met before revenue is recognised:

Turnover is derived from intermediation between medical professionals and legal teams on behalf of solicitors.

Revenue is measured at the fair value of invoices raised in respect of physiotherapy and medical appointments, net of discounts and excluding value added tax, and is recognised at the date the appointment is booked.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the year 0 0

The directors did not receive any remuneration in the year (2022: £nil).

3. Debtors

2023 2022
£ £
Trade debtors 9,251 17,756
Amounts owed by Group undertakings 3,212 2,057
Other debtors 4,739 7,294
17,202 27,107

4. Creditors: amounts falling due within one year

2023 2022
£ £
Trade creditors 52,179 56,419
Accruals 1,439 1,440
Corporation tax 0 1,789
53,618 59,648

5. Related party transactions

Transactions with the entity's directors

During the year advances of £820 (2022: £3,535) were paid to Mrs A Keeling. The maximum advanced during the year was £820 (2022: £3,535). Repayments of £3,375 (2022: £2,780) were made during the year. At the balance sheet date the outstanding balance was £2,950 (2022: £5,505). The loan is interest free and repayable on demand.

Other related party transactions

At year end the company was owed £11,264 (2022: £11,264) by a company under common control. Due to the concerns over the recoverability of this balance, the directors made the decision to provide in full for the balance during a prior period. The company under control went into liquidation following the year end.

During the year, the company transferred net funding of £3,951 to the parent company. During the year the parent company repaid £903. At the year end, the company was owed £5,105 (2022: £2,057) by the parent company.

6. Ultimate controlling party

Parent Company:

Injury Assess Medicals Limited
5 Woodcote View
Wilmslow
England
SK9 2DT

Injury Assess Medicals Limited, a company registered in England and Wales, company number 08797010, owns 100% of the share capital.

The overall controlling party is Mr D Keeling who owns 100% of the called up share capital of the parent company.